The biotech bi-weekly: the unveiling of a fully synthetic extracellular matrix and the takeover of a human tissue laboratory business

Over the past 2 weeks, a new line of fluorescent ligands designed for flexible labeling and a state-of-the-art agentic AI were unveiled. Several partnerships have blossomed, informing translational decision-making in rare diseases, uncovering how solid tumors survive and proliferate and validating AI-designed antibodies and peptides. Plus, a personnel appointment that plans to strengthen the pathway from translational research to new company creation. Products Unveiling a fully defined synthetic extracellular matrix Bio-Techne Corporation (MN, USA), a global provider of life science tools, reagents and diagnostic products, has announced the launch of Cultrex™ Synthetic Hydrogel, a fully defined synthetic extracellular matrix designed to support...